CAR T-cell therapy and critical care: A survival guide for medical emergency teams

Chimeric antigen receptor (CAR) T‑cells are genetically engineered to give T‑cells the ability to attack specific cancer cells, and to improve outcome of patients with refractory/relapsed aggressive B‑cell malignancies. To date, several CAR T‑cell products are approved and additional products with s...

Descripción completa

Detalles Bibliográficos
Autores principales: Messmer, Anna S., Que, Yok-Ai, Schankin, Christoph, Banz, Yara, Bacher, Ulrike, Novak, Urban, Pabst, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671280/
https://www.ncbi.nlm.nih.gov/pubmed/34613477
http://dx.doi.org/10.1007/s00508-021-01948-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671280/
https://www.ncbi.nlm.nih.gov/pubmed/34613477
http://dx.doi.org/10.1007/s00508-021-01948-2

Ejemplares similares